# Asia-Pacific Laboratory Nonhuman Primates (NHPs) Market to Reach USD 876 Million by 2034
The **Asia-Pacific Laboratory Nonhuman Primates (NHPs) market** was valued at **USD 472 million in 2026** and is projected to reach **USD 876 million by 2034**, registering a **CAGR of 9.9%** during the forecast period. Market growth is driven by increasing investments in biomedical research, expanding vaccine development programs, and rising demand for reliable preclinical animal models across pharmaceutical and biotechnology industries.
Laboratory Nonhuman Primates (NHPs), including cynomolgus macaques and rhesus monkeys, are widely used in preclinical safety studies, neuroscience research, infectious disease investigations, and vaccine development due to their close genetic and physiological similarity to humans. Their ability to provide highly predictive research outcomes makes them essential for advanced drug discovery and translational medicine.
Read Full Report: https://www.intelmarketresearc....h.com/asia-pacific-l
